UCB - Net Income

Stock Price
270.90
Daily Change
0.70 0.26%
Monthly
4.59%
Yearly
46.35%
Q1 Forecast
269.39

UCB reported EUR857M in Net Income for its fiscal semester ending in December of 2024.





Net Income Change Date
Alcon AG USD 237M 61M Sep/2025
Almirall EUR 19.58M 7M Dec/2025
Amarin USD -7.74M 6.4M Sep/2025
argenx SE USD 344.26M 98.9M Sep/2025
AstraZeneca USD 2.33B 207M Dec/2025
Bayer EUR -963M 764M Sep/2025
Galapagos EUR -202.11M 96.36M Sep/2025
Genmab DKK 336M 141M Jun/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 902M 250M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Orion EUR 260.5M 164.5M Dec/2025
Recordati EUR 117.31M 7.15M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
UCB EUR 857M 649M Dec/2024
Unibail Rodamco EUR 655.7M 581.2M Jun/2025